Greenwich LifeSciences

Greenwich LifeSciences

GLSI· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +87.1% in FY2025

Snehal Patel is the CEO of Greenwich LifeSciences and was paid $6.0M in FY2025 (Dec), down 4%.

Pay$100 in the stock at the end of FY21 → $86
CEO pay is from each Greenwich LifeSciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives1

See all
  1. 1Snehal PatelFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Greenwich LifeSciences paid CEO Snehal Patel $6.0M in FY2025 (Dec). No other named executive of that year is on file.

Name
Snehal PatelChief Executive Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Greenwich LifeSciences. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AOct 26, 2026FY2025
Annual report10-KJun 1, 2026FY2025
Proxy statementDEF 14ANov 3, 2025FY2024
Annual report10-KApr 15, 2025FY2024
Proxy statementDEF 14ANov 1, 2024FY2023
Annual report10-KApr 15, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data